Business
ProtoKinetix First in Series of Town Hall Shareholder Meetings
ProtoKinetix First in Series of Town Hall Shareholder Meetings.
About this update from Protokinetix, Inc.
[{"type":"text","content":"\n \n ProtoKinetix, Incorporated (www.protokinetix.com) \n (the \"Company\" or \"ProtoKinetix\") (OTCQB:PKTX) \n today announces that it will hold the first in a series of Town \n Hall Meetings. This meeting is being held to update shareholders \n on the current status of the company’s ongoing research projects. In \n addition, we will be outlining our vision of the way forward and \n reviewing some exciting new projects under consideration.\n \n \n The first two of these meetings have been scheduled for:\n \n \n \n Sunday, June 9, from 2:00 PM to 4:00 PM, at The Parkersburg Country \n Club located at 4910 1st Ave. Vienna, WV 26105. \n Appetizers and refreshments provided.\n \n \n Monday, June 10, from 5:00 PM to 7:00 PM, at The Buckhead Club \n located at 3344 Peachtree Road Suite 2600 Atlanta, GA 30326. \n Appetizers and refreshments provided.\n \n \n \n We look forward to meeting you and your guest. Please feel free to \n contact me if you have any questions concerning this event. RSVP via \n email is appreciated ([email protected]).\n \n \n About ProtoKinetix, Incorporated\n \n \n ProtoKinetix is a molecular biotechnology company that has developed and \n patented a family of hyper stable, potent glycopeptides (AAGP®) that \n enhance both engraftment and protection of transplanted cells used in \n regenerative medicine. Due to the results achieved over the last four \n years of testing, the University of Alberta has begun Phase 1 human \n clinical trials. Additional studies will be expanded to include whole \n organ transplantation and all therapies that are being developed \n globally to date; diabetes, retinal degeneration, cardiac repair and \n many other degenerative conditions. In addition, we are studying the \n potential impact on several cancer therapies.\n \n \n For more Company information and to join our email listing visit our \n website at ProtoKinetix.com.\n \n \n Cautionary Note Regarding Forward-Looking Statements\n \n \n The information discussed in this press release includes “forward \n looking statements” within the meaning of Section 27A of the Securities \n Act of 1933 (the “Securities Act”) and Section 21E of the Securities \n Exchange Act of 1934 (the “Exchange Act”). All statements, other \n than statements of historical facts, included herein conc...